(84 days)
No
The document describes a standard MRI scanner and its intended use. There is no mention of AI, ML, or any related technologies in the device description, intended use, or performance studies summary.
No.
The device is indicated for use as a diagnostic imaging device to produce images and/or spectra that, when interpreted by a trained physician, yield information that may assist in diagnosis. It does not provide therapy.
Yes
Explanation: The "Intended Use / Indications for Use" section explicitly states, "It is indicated for use as a diagnostic imaging device."
No
The device description explicitly states it is a "whole body magnetic resonance scanner" featuring a "superconducting magnet," "time-varying magnetic fields (gradients)," and "RF transmissions," which are all hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
- Device Function: The description clearly states that the 1.5T SIGNA Creator and 1.5T SIGNA Explorer is a magnetic resonance scanner. It produces images of the internal structures and functions of the body by using magnetic fields and radiofrequency transmissions. This is an in vivo imaging technique, meaning it examines the body directly, not specimens taken from the body.
- Intended Use: The intended use is to produce diagnostic images of various parts of the body. While these images are used to assist in diagnosis, the device itself is not analyzing biological samples.
Therefore, the device falls under the category of medical imaging devices, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
1.5T SIGNA Creator and 1.5T SIGNA Explorer is a whole body magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio, and short scan times. It is indicated for use as a diagnostic imaging device to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, and/or spectra, dynamic images of the structures and/or functions of the entire body, including, but not limited to, head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body. Depending on the region of interest being imaged, contrast agents may be used.
The images produced by 1.5T SIGNA Creator and 1.5T SIGNA Explorer reflects the spatial distribution or molecular environment of nuclei exhibiting magnetic resonance. These images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis.
Product codes
LNH
Device Description
1.5T SIGNA Creator and 1.5T SIGNA Explorer is a whole body magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio, and short scan times. The 1.5T SIGNA Creator and 1.5T SIGNA Explorer features a superconducting magnet operating at 1.5 Tesla. The system uses a combination of time-varying magnetic fields (gradients) and RF transmissions to obtain information regarding the density and position of nuclei exhibiting magnetic resonance. The data acquisition system accommodates 16 independent receive channels and multiple independent coil elements per channel during a single acquisition series.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Magnetic Resonance
Anatomical Site
entire body, including, but not limited to, head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use (Part 21 CFR 801 Subpart D)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Substantial Equivalence: 1.5T SIGNA Creator and 1.5T SIGNA Explorer and its applications underwent testing to comply with voluntary standards, including IEC60601-1. IEC60601-2-33, IEC60601-1-1, IEC60601-1-2. In addition, the following FDA-recognized performance standards were used to test the 1.5T SIGNA Creator and 1.5T SIGNA Explorer: NEMA MS1, MS2, MS3, MS4, MS5 and MS8. Additionally, the communication interface for the 1.5T SIGNA Creator and 1.5T SIGNA Explorer is designed to support DICOM format as defined in the NEMA PS PS3.1-3.20 set of standards. The predicate devices also complied with these standards.
As with the predicate devices, 1.5T SIGNA Creator and 1.5T SIGNA Explorer applied the following quality assurance measures:
- Risk Analysis
- Requirements Reviews
- Design Reviews
- Testing on unit level (Module verification)
- Integration testing (System verification)
- Performance testing (Verification)
- Safety testing (Verification)
- Simulated use testing (Validation)
Summary of Clinical Tests: The subject of this premarket submission, 1.5T SIGNA Creator and 1.5T SIGNA Explorer did not require clinical studies to support substantial equivalence. Internal scans were conducted as part of validation for workflow and image quality, and sample clinical images are included in the submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
1.5T Brivo MR355 and 1.5T Optima MR360 (K123417), 1.5T Optima MR450w (K142085)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus symbol, which features a staff with a serpent entwined around it, overlaid on three human profiles facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 4, 2015
GE Healthcare (GE Medical Systems, LLC) % Mr. Glen Sabin Regulatory Affairs Director 3200 N. Grandview Blvd. WAUKESHA WI 53188
Re: K143251
Trade/Device Name: 1.5T SIGNA Creator and 1.5T SIGNA Explorer Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: LNH Dated: November 7, 2014 Received: November 12, 2014
Dear Mr. Sabin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Robert A Ochs
Robert Ochs. Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K143251
Device Name
1.5T SIGNA Creator and 1.5T SIGNA Explorer
Indications for Use (Describe)
1.5T SIGNA Creator and 1.5T SIGNA Explorer is a whole body magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio, and short scan times. It is indicated for use as a diagnostic imaging device to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, and/or spectra, dynamic images of the structures and/or functions of the entire body, including, but not limited to, head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body. Depending on the region of interest being imaged, contrast agents may be used.
The images produced by 1.5T SIGNA Creator and 1.5T SIGNA Explorer reflects the spatial distribution or molecular environment of nuclei exhibiting magnetic resonance. These images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' intertwined in a stylized script, enclosed within a circular frame. The letters and the frame are colored in a bright blue hue, while the background within the circle is white. The overall design is simple, clean, and recognizable as the brand identity of General Electric.
GE Healthcare 510(k) Premarket Notification Submission
510(k) Summary
| In accordance with 21 CFR 807.92 the following summary of information is provided: | |
|---|---|
| Date: | November 7, 2014 |
| Submitter: | GE Healthcare (GE Medical Systems, LLC) |
| 3200 N. Grandview Blvd., | |
| Waukesha, WI 53188 | |
| USA | |
| Primary Contact Person: | Glen Sabin |
| Regulatory Affairs Director | |
| GE Healthcare | |
| Phone: 262-521-6848 | |
| Fax: 262-364-2785 | |
| Secondary Contact Person: | Ruoqian Liu |
| Regulatory Affairs Director | |
| GE Healthcare | |
| Phone: 86-10-58068943 | |
| Fax: 86-10-67803267 | |
| Device: | Trade Name: 1.5T SIGNA Creator, 1.5T SIGNA Explorer |
| Common/Usual Name: | Magnetic Resonance Imaging System |
| Classification Names: | Magnetic resonance diagnostic device |
| Product Code: | LNH |
| Predicate Device(s): | 1.5T Brivo MR355 and 1.5T Optima MR360 (K123417) |
| 1.5T Optima MR450w (K142085) | |
| Device Description: | 1.5T SIGNA Creator and 1.5T SIGNA Explorer is a whole body |
| magnetic resonance scanner designed to support high resolution, | |
| high signal-to-noise ratio, and short scan times. The 1.5T SIGNA | |
| Creator and 1.5T SIGNA Explorer features a superconducting | |
| magnet operating at 1.5 Tesla. The system uses a combination of | |
| time-varying magnetic fields (gradients) and RF transmissions to | |
| obtain information regarding the density and position of nuclei | |
| exhibiting magnetic resonance. The data acquisition system | |
| accommodates 16 independent receive channels and multiple | |
| independent coil elements per channel during a single acquisition | |
| series. |
4
GE Healthcare 510(k) Premarket Notification Submission
-
1.5T SIGNA Creator and 1.5T SIGNA Explorer is a whole body Intended Use: magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio, and short scan times. It is indicated for use as a diagnostic imaging device to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, and/or spectra, dynamic images of the structures and/or functions of the entire body, including, but not limited to, head, neck. TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body. Depending on the region of interest being imaged, contrast agents may be used.
The images produced by 1.5T SIGNA Creator and 1.5T SIGNA Explorer reflect the spatial distribution or molecular environment of nuclei exhibiting magnetic resonance. These images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis. -
Proposed 1.5T SIGNA Creator and 1.5T SIGNA Explorer Technology: employs the same fundamental scientific technology as its predicate device 1.5T Brivo MR355 and 1.5T Optima MR360 (K123417).
Determination of Summary of Non-Clinical Tests:
Substantial Equivalence: 1.5T SIGNA Creator and 1.5T SIGNA Explorer and its applications underwent testing to comply with voluntary standards, including IEC60601-1. IEC60601-2-33, IEC60601-1-1, IEC60601-1-2. In addition, the following FDA-recognized performance standards were used to test the 1.5T SIGNA Creator and 1.5T SIGNA Explorer: NEMA MS1, MS2, MS3, MS4, MS5 and MS8. Additionally, the communication interface for the 1.5T SIGNA Creator and 1.5T SIGNA Explorer is designed to support DICOM format as defined in the NEMA PS PS3.1-3.20 set of standards. The predicate devices also complied with these standards.
As with the predicate devices, 1.5T SIGNA Creator and 1.5T SIGNA Explorer applied the following quality assurance measures:
- Risk Analysis ●
- Requirements Reviews
- Design Reviews
- Testing on unit level (Module verification)
- Integration testing (System verification)
5
Image /page/5/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' in a stylized, cursive font, enclosed within a blue circle. The circle has a swirling design around the letters, giving it a dynamic and recognizable appearance. The logo is simple, yet iconic, representing the brand identity of General Electric.
- Performance testing (Verification)
- . Safety testing (Verification)
- Simulated use testing (Validation)
Summary of Clinical Tests:
The subject of this premarket submission, 1.5T SIGNA Creator and 1.5T SIGNA Explorer did not require clinical studies to support substantial equivalence. Internal scans were conducted as part of validation for workflow and image quality, and sample clinical images are included in the submission.
Substantial Equivalence Conclusion:
The indications for use of the proposed systems and the predicates are nearly identical. The name of the device has changed and minor updates were made to the feature set. 1.5T SIGNA Creator and 1.5T SIGNA Explorer employs equivalent technology to the reference devices. Additionally, the result of the above described testing demonstrates that the device performs as intended.
- GE Healthcare considers the 1.5T SIGNA Creator and 1.5T Conclusion: SIGNA Explorer to be as safe, as effective, and performance is substantially equivalent to the predicate device(s).